Yong-Mei Cha
Mayo Clinic
Internal medicineRadiologySurgeryMagnetic resonance imagingLead (electronics)CardiologyRetrospective cohort studyIntensive care medicineCardiac resynchronization therapyCatheter ablationVentricular tachycardiaImplantable cardioverter-defibrillatorHeart failureAblationAtrial fibrillationPulmonary veinVentricular fibrillationIn patientIncidence (epidemiology)Medical emergencyMedicineEjection fraction
132Publications
13H-index
536Citations
Publications 138
Newest
#1Verda Arshad (Mayo Clinic)
#2Larry M. Baddour (Mayo Clinic)H-Index: 90
Last. M. Rizwan Sohail (BCM: Baylor College of Medicine)H-Index: 20
view all 9 authors...
BACKGROUND Optimal timing of cardiovascular implantable electronic device (CIED) re-implantation following device removal due to infection is undefined. Multinational guidelines reflect this and include no specific recommendation for this timing, while others have recommended waiting at least 14 days in cases of CIED related infective endocarditis (CIED-IE). The current work seeks to clarify this issue. METHODS We retrospectively reviewed institutional data at Mayo Clinic, Minnesota of patients ...
Source
#1Banveet Kaur Khetarpal (UNLV: University of Nevada, Las Vegas)H-Index: 1
#2Justin Z. Lee (Mayo Clinic)H-Index: 10
Last. Komandoor Srivathsan (Mayo Clinic)H-Index: 17
view all 11 authors...
BACKGROUND Many advanced heart failure patients have both a left ventricular assist device (LVAD) and an implantable cardioverter-defibrillator (ICD). This study examines incidence, clinical impact, and management of LVAD-related EMI. METHODS We performed a three-center retrospective analysis of transvenous ICD implanted patients with LVAD implanted between January 1, 2005 and December 31, 2020. The primary outcome was EMI after LVAD implantation, categorized as LVAD-related noise or telemetry i...
Source
Source
Source
Source
Source
#2Jose R. Medina-Inojosa (Mayo Clinic)H-Index: 15
Last. Yong-Mei Cha (Mayo Clinic)H-Index: 13
view all 12 authors...
Abstract Objective: To determine whether early Roux-en-Y gastric bypass surgery (RYGB) reduces the risk of MACE in patients with obesity. Patients and Methods: We conducted a study of patients with class II and III obesity (body mass index [BMI] >35 kg/m2) from Olmsted County, Minnesota, that underwent obesity clinic consultation between the years 1993-2012, and had either RYGB surgery within one year (RYGB-1Y group), or medically managed (No-RYGB group). The composite endpoint of MACE (all-caus...
Source
#1Gurukripa N. Kowlgi (Mayo Clinic)H-Index: 3
#2Yong-Mei Cha (Mayo Clinic)H-Index: 13
Source
#1Andrea M. Russo (Rowan University)H-Index: 23
#2Emily P. Zeitler (Dartmouth–Hitchcock Medical Center)H-Index: 13
Last. Jeanne E. Poole (University of Washington Medical Center)H-Index: 50
view all 11 authors...
Background: Among patients with atrial fibrillation (AF), women are less likely to receive catheter ablation, and may have more complications and less durable results. Most information regarding se...
4 CitationsSource
#1Fatima M. Ezzeddine (Mayo Clinic)H-Index: 1
#2Antoine N. Saliba (Mayo Clinic)H-Index: 2
Last. Yong-Mei Cha (Mayo Clinic)H-Index: 13
view all 7 authors...
BACKGROUND Several chemotherapy agents are associated with the development of non-ischemic cardiomyopathy (NIC). When chemotherapy-induced cardiomyopathy (CHIC) is associated with left bundle branch block (LBBB) and a left ventricular ejection fraction (LVEF) 35% or lower, cardiac resynchronization therapy (CRT) is often utilized to improve cardiac function and relieve symptoms. OBJECTIVE To determine the echocardiographic and clinical outcomes of CRT in patients with CHIC. METHODS The study inc...
Source